Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
374,002,024
-
Total 13F shares
-
189,802,726
-
Share change
-
+12,528,169
-
Total reported value
-
$3,506,437,914
-
Put/Call ratio
-
205%
-
Price per share
-
$18.47
-
Number of holders
-
308
-
Value change
-
+$215,548,348
-
Number of buys
-
120
-
Number of sells
-
155
Institutional Holders of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) as of Q4 2018
As of 31 Dec 2018,
Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
189,802,726 shares.
The largest 10 holders included
PAULSON & CO. INC., ValueAct Holdings, L.P., Vanguard Group Inc, Connor, Clark & Lunn Investment Management Ltd., NOMURA HOLDINGS INC, GLENVIEW CAPITAL MANAGEMENT, LLC, FIL Ltd, WELLINGTON MANAGEMENT GROUP LLP, MILLER VALUE PARTNERS, LLC, and GOLDENTREE ASSET MANAGEMENT LP.
This page lists
308
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.